why choose us

First received: June 30, 2023

Clinical Trial: A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Overweight or Obesity

Study Type: INTERVENTIONAL


Official Title: A Phase 2b, Double-Blind Study to Investigate the Effect of LY3437943 on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Brief Summary: The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes (T2D).The study will lasts around 31 weeks.

Read more